JORDAN TYMESON: Open Payments
NPI 1942071923 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 12 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $771 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $79 |
| Genentech USA, Inc. | 2 | $55 |
| Amgen Inc. | 3 | $54 |
| Calliditas Therapeutics US Inc. | 1 | $31 |
| Ardelyx, Inc. | 1 | $27 |
| Mallinckrodt Hospital Products Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: JYNARQUE, KRYSTEXXA, Ocrevus, TARPEYO, VOYXACT, IBSRELA, ACTHAR, Gazyva.
Industry payments across NY — which companies pay providers there.
